Please assess the completion status of the following clinical trial:

Trial Title: Study of an Investigational Drug, RO7239361 (BMS-986089), in Ambulatory Boys With DMD

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE1/PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosed with DMD~* Able to walk without assistance~* Able to walk up 4 stairs in 8 seconds or less~* Weigh at least 15 kg~* Taking corticosteroids for DMD~Exclusion Criteria:~* Ejection fraction \< 55% on echocardiogram, based on central read~* Any behavior or mental issue that will affect the ability to complete the required study procedures~* Previously or currently taking medications like androgens or human growth hormone~* Use of a ventilator during the day~* Unable to have blood samples collected or receive an injection under the skin~* Treatment with exon skipping therapies 6 months prior to study start~* Treatment with ataluren or any investigational drug currently or within 5 half-lives prior to study start

- Gender: MALE
- Minimum Age: 5 Years
- Maximum Age: 10 Years
- Healthy Volunteers: f

Study Arms:
- RO7239361 (Type: ACTIVE_COMPARATOR): RO7239361 subcutaneous injections on specified days
- Placebo (Type: PLACEBO_COMPARATOR): Placebo subcutaneous injections on specified days

Based on this trial design, predict the completion outcome and termination type (if applicable).